Current Pharmacogenomics and Personalized Medicine
Title: Editorial [Sentence First, Verdict Afterwards: Using Value of Information Analysis to Inform Decisions about Pharmacogenomic Test Adoption and Research]
Volume: 8 Issue: 3
Author(s): Don Husereau
Affiliation:
Keywords: Decision analysis, genetic tests, personalized medicine, pharmacogenomics, reimbursement, research priority setting, uncertainty, value of information analysis
Export Options
About this article
Cite this article as:
Husereau Don, Editorial [Sentence First, Verdict Afterwards: Using Value of Information Analysis to Inform Decisions about Pharmacogenomic Test Adoption and Research], Current Pharmacogenomics and Personalized Medicine 2010; 8 (3) . https://dx.doi.org/10.2174/187569210792246335
DOI https://dx.doi.org/10.2174/187569210792246335 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Endothelial Growth Factor (VEGF) in the Pathogenesis of Diabetic Nephropathy of Type 1 Diabetes Mellitus
Current Drug Targets Pharmacological Treatment of Hypertension in Pregnancy
Current Pharmaceutical Design Predictive Genomics DNA Profiling for Athletic Performance
Recent Patents on DNA & Gene Sequences Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets An RP-HPLC Method for Quantitative Analysis of Linagliptin Entrapped in Nanotransfersomes and its Application to Skin Permeation Studies
Current Pharmaceutical Analysis Effect of Alpha-1-Acid Glycoprotein Binding on Pharmacokinetics and Pharmacodynamics
Current Drug Metabolism Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
Current Drug Safety The Role of Older Age in Normocytic Anaemia in Type 2 Diabetes Mellitus
Current Aging Science Hepatocellular Carcinoma: Important Biomarkers and their Significance in Molecular Diagnostics and Therapy
Current Medicinal Chemistry Meet Our Editorial Board Member
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Intein-Mediated Expression and Purification of an Analog of Glucagon-like Peptide-1 in Escherichia coli
Protein & Peptide Letters Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?
CNS & Neurological Disorders - Drug Targets TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review
Coronaviruses The Psoriasis Genetics as a Model of Complex Disease
Current Drug Targets - Inflammation & Allergy Metabolic Features Across the Female Life Span in Women with PCOS
Current Pharmaceutical Design IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets MicroRNA Expression in Coronary Artery Disease
MicroRNA High-Throughput Evaluation of CYP1A1 and 2B1 Induction in Rat Liver Slices Using a Semi-Automated System
Drug Metabolism Letters